Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy

• Register: ClinicalTrials.gov
• Last refreshed on: 9 March 2015
• Main ID: NCT02369822
• Date of registration: 11/02/2015
• Prospective Registration: No
• Primary sponsor: Ain Shams University
• Public title: Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy
• Scientific title: Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy
• Date of first enrolment: February 2015
• Target sample size: 60
• Recruitment status: Active, not recruiting
• URL: http://clinicaltrials.gov/show/NCT02369822
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: Phase 2

Countries of recruitment

Egypt

Contacts

• Name: Iman A Elagouza, A Professor
• Affiliation: Faculty of Medicine, Ain Shams University

Key inclusion & exclusion criteria

Inclusion Criteria:

- Normal neuroimaging

Exclusion Criteria:

- Developmental delay.

- Suspected metabolic problems.



Age minimum: 2 Years
Age maximum: 16 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Idiopathic Epilepsy

Intervention(s)

Dietary Supplement: Vitamin C

Primary Outcome(s)

Seizure severity and frequency, EEG findings [Time Frame: up to 30 days]

Secondary Outcome(s)

vitamin C level in children with epilepsy [Time Frame: 6 months]

Secondary ID(s)

Vitamin C, Children, Epilepsy

Source(s) of Monetary Support

Please refer to primary and secondary sponsors